MONALISA references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Monalisa PN
Monalisa PN is a polynucleotide dermal filler by Monalisa, formulated for soft tissue augmentation and restoration of facial lipoatrophy. The product contains stabilized polynucleotides at 20 mg/mL with 0.3% lidocaine and is intended for professional use only.
Key Benefits of Monalisa PN
- Supports soft-tissue augmentation
- Helps restore facial lipoatrophy
- Contains stabilized polynucleotides (PN) for tissue support
- Includes 0.3% lidocaine to improve injection comfort
- For professional intradermal injection
Indications and Professional Use
Main indications
- Facial lipoatrophy
- Soft tissue augmentation
- Facial tissue restoration
- Intradermal aesthetic correction
Professional use
Professional use: For use by licensed medical professionals only, following clinical assessment. Intended for intradermal injection only. Contraindications: Known hypersensitivity to sodium polynucleotide, lidocaine, or other amide-type anaesthetics. Allergic, autoimmune or sarcoid granulomatous disease, or endocarditis. Bleeding disorders, or use of thrombolytic agents, aggregation inhibitors, NSAIDs, anticoagulants or immunosuppressants. Pregnancy or breastfeeding. Patients under 18. Professional-use restrictions: Do not inject into blood vessels. Do not inject where another manufacturer's product is present, or where a non-biodegradable implant is already present.
Treatment areas
- Face
- Facial lipoatrophy-affected areas
- Soft tissue restoration areas
Patient profile
Suitable for adult patients (18+) presenting with facial lipoatrophy or soft tissue volume loss appropriate for intradermal polynucleotide correction, as determined by the treating practitioner. Not suitable for pregnant or breastfeeding patients, or those meeting any contraindication above.
How Monalisa PN Works
Monalisa PN works through stabilized polynucleotides (20 mg/mL) that support soft-tissue augmentation and restoration in areas affected by facial lipoatrophy, with 0.3% lidocaine for injection comfort. It is intended for intradermal aesthetic correction and facial tissue restoration in patients over 18.
Why Order From Allpara
Allpara offers genuine, verified MONALISA products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
What is Monalisa PN?
Monalisa PN is an injectable polynucleotide dermal filler with lidocaine manufactured by GENOSS Co., Ltd. It is a sterile, transparent gel of stabilized polynucleotides containing 0.3% lidocaine.
Is Monalisa PN biodegradable?
Yes. Monalisa PN is a bio-absorbable gel that is gradually absorbed by the body. The duration varies according to individual factors and treatment-related variables.
More from GENOSS
Clinic alternatives
Pick up where you left off
Monalisa PN
Monalisa PN is a polynucleotide dermal filler by Monalisa, formulated for soft tissue augmentation and restoration of facial lipoatrophy. The product contains stabilized polynucleotides at 20 mg/mL with 0.3% lidocaine and is intended for professional use only.
Key Benefits of Monalisa PN
- Supports soft-tissue augmentation
- Helps restore facial lipoatrophy
- Contains stabilized polynucleotides (PN) for tissue support
- Includes 0.3% lidocaine to improve injection comfort
- For professional intradermal injection
Indications and Professional Use
Main indications
- Facial lipoatrophy
- Soft tissue augmentation
- Facial tissue restoration
- Intradermal aesthetic correction
Professional use
Professional use: For use by licensed medical professionals only, following clinical assessment. Intended for intradermal injection only. Contraindications: Known hypersensitivity to sodium polynucleotide, lidocaine, or other amide-type anaesthetics. Allergic, autoimmune or sarcoid granulomatous disease, or endocarditis. Bleeding disorders, or use of thrombolytic agents, aggregation inhibitors, NSAIDs, anticoagulants or immunosuppressants. Pregnancy or breastfeeding. Patients under 18. Professional-use restrictions: Do not inject into blood vessels. Do not inject where another manufacturer's product is present, or where a non-biodegradable implant is already present.
Treatment areas
- Face
- Facial lipoatrophy-affected areas
- Soft tissue restoration areas
Patient profile
Suitable for adult patients (18+) presenting with facial lipoatrophy or soft tissue volume loss appropriate for intradermal polynucleotide correction, as determined by the treating practitioner. Not suitable for pregnant or breastfeeding patients, or those meeting any contraindication above.
How Monalisa PN Works
Monalisa PN works through stabilized polynucleotides (20 mg/mL) that support soft-tissue augmentation and restoration in areas affected by facial lipoatrophy, with 0.3% lidocaine for injection comfort. It is intended for intradermal aesthetic correction and facial tissue restoration in patients over 18.
Why Order From Allpara
Allpara offers genuine, verified MONALISA products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
What is Monalisa PN?
Monalisa PN is an injectable polynucleotide dermal filler with lidocaine manufactured by GENOSS Co., Ltd. It is a sterile, transparent gel of stabilized polynucleotides containing 0.3% lidocaine.
Is Monalisa PN biodegradable?
Yes. Monalisa PN is a bio-absorbable gel that is gradually absorbed by the body. The duration varies according to individual factors and treatment-related variables.